Stock analysts at StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a research note issued to investors on Monday. The brokerage set a “sell” rating on the stock.
Ampio Pharmaceuticals Stock Performance
Shares of NYSE AMPE opened at $0.00 on Monday. Ampio Pharmaceuticals has a 52 week low of $0.00 and a 52 week high of $7.47. The firm has a market capitalization of $2,497.00, a P/E ratio of 0.00 and a beta of 3.67.
About Ampio Pharmaceuticals
Want More Great Investing Ideas?
Featured Articles
- Five stocks we like better than Ampio Pharmaceuticals
- The Basics of Support and Resistance
- Goldman Sachs Earnings Reveal Market Moves Investors Can’t Ignore
- How to Use the MarketBeat Excel Dividend Calculator
- AMD Gains Momentum With AI: Can It Beat Expectations?
- Overbought Stocks Explained: Should You Trade Them?
- Lithium Grab: 2 Lithium Stocks That Could Be Takeover Targets
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.